Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 3,232 shares at $45.06 ($146K) on 2024-02-01, disclosed to the SEC on 2024-02-05.
Open-market sale of $146k RYTM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.06 | 1,616 | $73K | 50.0% |
| 2 | $45.06 | 1,616 | $73K | 50.0% |
| Total | $45.06 avg | 3,232 | $146K | 100% |
| Filing → |
| RYTM | SELL | 2026-02-12 | $1.2M | — | Filing → |
| RYTM | SELL | 2026-02-06 | $1.4M | — | Filing → |
| RYTM | SELL | 2025-08-14 | $5.1M | — | Filing → |